午夜插插,噜噜噜影院,啪啪伊人网,欧美熟夫,景甜吻戏视频,男人强操性感蕾丝美女视频在线网站,日本美女跳舞视频

Welcome to chemicalbook!
+1 (818) 612-2111
RFQ
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

RFQ
skype
MY Account
Top
Postion:Product Catalog >API>Circulatory system drugs>Antiarrhythmics Drugs>Procainamide
Procainamide
  • Procainamide

Procainamide NEW

Price $33
Package 200mg
Min. Order:
Supply Ability: 10g
Update Time: 2025-07-10

Product Details

Product Name: Procainamide CAS No.: 51-06-9
Purity: 98.86% Supply Ability: 10g
Release date: 2025/07/10

Product Introduction

Bioactivity

NameProcainamide
DescriptionProcainamide (Novocainamide) is a specific and potent DNA methyltransferase 1 (DNMT1) inhibitor and a Class 1A antiarrhythmic agent, with potential applications in cancer and arrhythmia research [1] [2].
In vitroHCT116, HCT116 DNMT1?/?, and HCT116 DNMT3b?/? cells were treated with PBS, pH 7.4 or 0.5 mM procainamide for 96 h. Procainamide treatment of HCT116 DNMT3b?/? cells decreased m5dC content by 11.5%, but treatment of HCT116 DNMT1?/? cells did not decrease m5dC content. These results suggested that DNMT1 was the intracellular target of procainamide[1].
StoragePure form: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility InformationDMSO : 45 mg/mL (191.22 mM), Sonication is recommended.
KeywordsProcainamide | DNMT1 | DNAMethyltransferase | DNA Methyltransferase
Inhibitors RelatedDecitabine | GSK-3484862 | Levetiracetam | Dihydro-5-azacytidine FA | 5-Azacytidine | Procainamide hydrochloride | SW155246 | Zebularine | γ-Oryzanol | 6-Thioguanine | 5-Methyl-2'-deoxycytidine | Hinokitiol
Related Compound LibrariesMethylation Compound Library | Failed Clinical Trials Compound Library | Epigenetics Compound Library | Hematonosis Compound Library | Drug Repurposing Compound Library | Inhibitor Library | Anti-Cardiovascular Disease Compound Library | Anti-Cancer Approved Drug Library | FDA-Approved Drug Library | Bitter Compound library | Anti-Cancer Active Compound Library | Anti-Cancer Drug Library

Company Profile Introduction

Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers. TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.

You may like

Recommended supplier

Product name Price   Suppliers Update time
$0.00/25KG
VIP6Y
Hebei Mujin Biotechnology Co.,Ltd
2023-10-11
$0.00/1kg
VIP6Y
Hebei Yanxi Chemical Co., Ltd.
2023-10-13
$59.00/100mg
VIP3Y
TargetMol Chemicals Inc.
2025-05-02
$1.10/1g
VIP5Y
Dideu Industries Group Limited
2021-08-11
$1.00/1KG
VIP6Y
Career Henan Chemical Co
2020-02-04
  • Since: 2011-01-07
  • Address: 36 Washington Street, Wellesley Hill, MA
INQUIRY